Rock Creek Capital — 2025 Investments

1 investments dated 2025 · listed companies and verified rows first · show all

General Proximitygeneralproximity.bio in 𝕏Jan 2025

General Proximity develops proximity-based technologies for drug discovery and development.

AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US

Armand Cognetta(Founder)inMatthias PauthnerCorentine Laurin(Principal Scientist, Medicinal Chemistry)Veronica Fulton(Chief of Staff)Benji Dote(EA)Reen Ramos(EA)

Co-investorsY Combinator age1 Felicis Ventures Freemind Investments Lifespan Vision Ventures Mana Ventures +3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.